ImmunityBio, Inc. (NYSE: IBRX), a commercial stage immunotherapy company developing next generation therapies that drive immunological memory and restore immune competence, today announced that the ...
German generics and consumer healthcare major STADA Arzneimittel today said it has committed to investing more than 85 million euros ($100.7 million) in a state-of-the-art manufacturing facility in ...
Lifera’s summit in Riyadh highlighted Saudi Arabia’s biotech potential, focusing on collaboration, AI, and infrastructure to address global health challenges ...
As Saudi Arabia strives to secure a spot for itself on the global biopharma scene, Germany’s Stada has become one of the ...
The MarketWatch News Department was not involved in the creation of this content. -- Co-chaired by Her Royal Highness Dr. Haya bint Khaled Al Saud, His Excellency Dr. Bandar Alknawy, and Dr. Patrick ...
LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- In a historic step toward positioning Saudi Arabia as a global hub for biotechnology, Sarat Ventures Y Innovations Biotech Fund (UK) announced today the ...
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia has concluded its landmark debut at the BIO International Convention 2025, having signed more than a dozen partnerships, launched a national ...
Co-chaired by Her Royal Highness Dr. Haya bint Khaled Al Saud, His Excellency Dr. Bandar Alknawy, and Dr. Patrick Soon-Shiong Convening national government, scientific, and investment leaders from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results